Selected by the World Economic Forum as one of 2018’s most promising Technology Pioneers - 1928 Diagnostics is a company on a mission to save the power of antibiotics by addressing the growing and alarming problem of antimicrobial resistance. 1928 Diagnostics provides hospitals and care professionals with a digital tool to track, stop and predict outbreaks of infections caused by superbugs.
Join us in this fireside chat with Kristina Lagerstedt, CEO and Co-Founder of 1928 Diagnostics, as we discuss:
Dr. Kristiana Lagerstedt is a health tech entrepreneur with over 15 years of experience in clinical research at Sahlgrenska University hospital. She believes in the power of collaboration to drive ideas that create impact. In 2019, 1928 Diagnostics was one of the ten finalists in the Nordic Norrsken Award.
1928 Diagnostics
CEO & Co-founder
Dr. Kristina Lagerstedt is a tech and healthcare entrepreneur and scientist, born and raised in Stockholm, Sweden, who founded the digital health company 1928 Diagnostics and serves as its CEO. 1928 Diagnostics offers a DNA analytics platform to hospitals and public health laboratories globally for impact infection control and diagnostics. The 1928 platform track and profiles microorganisms to…
Göteborg University
Innovation Advisor
Become a Chapter Director
View ProfileStartup Grind
Director, Global Community
View Profile